|
Souvenaid is the name of a medical nutrition formulation, presented as a drink, that has been studied for potential use in the dietary management of early Alzheimer's disease.〔Sijben JWC, de Wilde MC, Wieggers R, Groenendijk M, Kamphuis PJGH. A multi nutrient concept to enhance synapse formation and function: science behind a medical food for Alzheimer's disease. OCL 2011;18:267-270. doi : 10.1684/ocl.2011.0410〕 A NPS MedicineWise summary stated that (based on three randomized controlled trials) that Souvenaid failed to show a significant effect in decreasing the rate of cognitive decline or delaying progression of Alzheimer's disease, but that there may be a minor improvement in memory in drug-naïve persons in the very early stages of the disease. Souvenaid was developed by Advanced Medical Nutrition division of Nutricia and contains a patented combination of nutrients, referred to under the trademark Fortasyn Connect™.〔(【引用サイトリンク】title=Souvenaid Consumer : Home )〕 ==Composition 〔(【引用サイトリンク】title=Medscape: Medscape Access )〕== *Eicospentaenoic acid, 300 mg *Docosahexaenoic acid, 1200 mg *Phospholipids 106 mg *Choline, 400 mg *Uridine monophosphate, 625 mg *Vitamin E (alpha-tocopherol equivalents), 40 mg *Selenium, 60 µg *Vitamin B12, 3 µg *Vitamin B6, 1 mg *Folic acid, 400 µg *Vitamin C, 80 mg 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Souvenaid」の詳細全文を読む スポンサード リンク
|